A new trading day began on Monday, with Merus N.V (NASDAQ: MRUS) stock price down -7.14% from the previous day of trading, before settling in for the closing price of $96.92. MRUS’s price has ranged from $33.19 to $97.14 over the past 52 weeks.
A company in the Healthcare sector has dropped its sales by -8.04% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged -69.32%. With a float of $31.55 million, this company’s outstanding shares have now reached $75.84 million.
Merus N.V (MRUS) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Merus N.V is 58.40%, while institutional ownership is 87.69%. The most recent insider transaction that took place on Dec 23 ’25, was worth 54,421,074. In this transaction 10% Owner of this company bought 561,042 shares at a rate of $97.00, taking the stock ownership to the 72,589,817 shares. Before that another transaction happened on Dec 26 ’25, when Company’s 10% Owner bought 142,610 for $97.00, making the entire transaction worth $13,833,170. This insider now owns 72,828,509 shares in total.
Merus N.V (MRUS) Latest Financial update
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.49 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.29 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -69.32% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -3.71% during the next five years compared to -8.04% drop over the previous five years of trading.
Merus N.V (NASDAQ: MRUS) Trading Performance Indicators
Here are Merus N.V’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 7.97. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 120.58.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.33, a number that is poised to hit -1.11 in the next quarter and is forecasted to reach -4.93 in one year’s time.
Technical Analysis of Merus N.V (MRUS)
Let’s dig in a bit further. During the last 5-days, its volume was 0.83 million. That was inferior than the volume of 1.27 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 43.23%.
During the past 100 days, Merus N.V’s (MRUS) raw stochastic average was set at 79.59%, which indicates a significant increase from 28.60% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.85 in the past 14 days, which was lower than the 1.12 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $95.71, while its 200-day Moving Average is $67.79. However, in the short run, Merus N.V’s stock first resistance to watch stands at $95.53. Second resistance stands at $101.05. The third major resistance level sits at $105.25. If the price goes on to break the first support level at $85.81, it is likely to go to the next support level at $81.61. The third support level lies at $76.09 if the price breaches the second support level.
Merus N.V (NASDAQ: MRUS) Key Stats
With a market capitalization of 6.83 billion, the company has a total of 75,847K Shares Outstanding. Currently, annual sales are 36,130 K while annual income is -215,330 K. The company’s previous quarter sales were 12,150 K while its latest quarter income was -95,520 K.
